TF Capital

TF Capital

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

China, Pudong

About

The VC's location is in Asia, China. The main office of this VC is situated in Pudong.

The fund typically invests in rounds with 3-4 participants. Along with TF Capital, start-ups are often financed by Qiming Venture Partners, Sequoia Capital China, Kleiner Perkins. The fund often co-invests with Qiming Venture Partners, Sinopharm Capital, Sequoia Capital China, overall with 2 funds from our list. In subsequent rounds, the fund is usually supported by Sequoia Capital China, OrbiMed, Lapam Capital, out of 1 investor from our database.

The country of its foundation and the country of the most frequent investments for the fund coincides - China. The fund has a preferred number of founders for start-ups that it invests in. ZAI Lab, Antengene Corporation, Asieris Pharmaceuticals are among the most popular portfolio start-ups of the fund. Among their most successful investment fields, we have identified Biopharma, Pharmaceutical. Also, because of its portfolio diversification tendency, we can highlight 8 more industries for this fund. Also, a start-up has to be aged 2-3 years to expect investment from this fund.

TF Capital participates, on average, in 22 percentage points less than the average amount of lead investments in other funds. Deals in the range of 10 - 50 millions dollars are most common for this fund. In real terms, this VC performs 13 percentage points less exits than other funds. The fund usually participates in 2-6 investment rounds per year. This fund was the most active in 2018. Additionally, in 2019 the fund was active. We recorded the biggest number of exits for this fund in 2017.

Besides the listed founders, we have found 1 key employee of this fund in our database.

Fund Activity

Operative

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

16.7% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]

x4

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

9.4 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.35 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]

1

Funds Investing in Following
Rounds

Sequoia Capital China, OrbiMed, Lapam Capital

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: